Dose-escalation Study of Lupartumab Amadotin (BAY1129980)

NCT02134197 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
69
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer